New thumb implant could speed recovery from arthritis surgery
NCT ID NCT06078189
First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 2 times
Summary
This study compares two surgical treatments for rhizarthrosis, a type of arthritis at the base of the thumb. One group gets a new prosthesis (HORUS implant), the other gets the standard trapezectomy. Researchers will measure hand function and pain in 50 patients over the short term to see which approach leads to faster recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- HORUS trapezium-metacarpal prosthesis (a device)
- What this could lead to
- If the prosthesis works better, it could offer faster recovery and less pain than the standard surgery for thumb arthritis.
- What could go wrong
- This is a small, early-stage trial with only 50 people, so results may not apply to everyone. The new device could have complications or not improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2023
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with symptomatic disabling osteoarthritis in failure of medical treatment
- Ages
-
45 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age \>45 years 2. Symptomatic trapezius-metacarpal osteoarthritis after failure of medical treatment ( night orthosis 3 months + failure of 2 infiltrations/year) 3. Patient who has given his/her consent to participate in the study after being informed by the surgeon, 4. Patient living in France and able to answer the survey alone. 5. Subject affiliated to a social security system or beneficiary of such a system 6. No participation in any other clinical study Exclusion Criteria: 1. Minor patient 2. Trapezium height \< 8 mm 3. Major subject protected by law, under curatorship or guardianship 4. Known allergy to the materials of the medical device 5. Local infection 6. Local skin necrosis or unhealed wound 7. Pregnant or nursing women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rhizarthrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Clinique BIZET
RECRUITINGParis, 75116, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.